Ticker Details
Third Harmonic Bio, Inc.
IPO Date:	September 15, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$242.79M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.27 | 2.70%
Avg Daily Range (30 D):	$0.02 | 0.30%
Avg Daily Range (90 D):	$0.03 | 0.59%

Institutional Daily Volume
Avg Daily Volume:	.19M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.39M

Trade Size
Avg Trade Size (Sh.):	110
Avg Trade Size (Sh.) (30 D):	128
Avg Trade Size (Sh.) (90 D):	136

Institutional Trades
Total Institutional Trades:	111
Avg Institutional Trade:	$2.23M
Avg Institutional Trade (30 D):	$.92M
Avg Institutional Trade (90 D):	$1.85M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.36M
Avg Closing Trade (30 D):	$1.85M
Avg Closing Trade (90 D):	$1.85M
Avg Closing Volume:	328.83K

News

Apr 14, 2025 @ 10:45 AM Third Harmonic Bio Announces Plan of Liquidation a... Source: N/A

Feb 12, 2025 @ 9:41 PM Third Harmonic Bio Initiates Strategic Review, Lay... Source: Vandana Singh

Nov 7, 2024 @ 9:00 PM Third Harmonic Bio to Participate in Upcoming Inve... Source: N/A

May 28, 2024 @ 8:05 PM Third Harmonic Bio to Participate in the Jefferies... Source: Third Harmonic Bio

May 15, 2024 @ 4:12 PM Biogen (BIIB) Partner Begins Filing for Leqembi SC... Source: Zacks Equity Research

Financials
	TTM	TTM	Q1 2025
Basic EPS	$1.29	$1.23	$.35
Diluted EPS	$1.26	$1.23	$.35
Revenue	$90.73M	$12.86M	$2.89M
Gross Profit	$65.65M
Net Income / Loss	$36.09M	$-53.45M	$-15.83M
Operating Income / Loss	$8.15M	$-66.3M	$-18.72M
Cost of Revenue	$25.08M
Net Cash Flow	$10.42M	$15.99M	$M
PE Ratio